Status:
UNKNOWN
Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection
Lead Sponsor:
University of Pretoria
Conditions:
Prevention of Postpartum Sepsis
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Randomised controlled trial to investigate the efficacy of adding metronidazole pre-operatively to kefazolin in reducing postpartum infection
Detailed Description
All pregnant patients scheduled for emergency or elective Caesarean section ≥18 years, willing and able to provide informed consent and not receiving antibiotics, will be eligible for recruitment. Pat...
Eligibility Criteria
Inclusion
- 18 years and older Willing and able to provide written informed consent
Exclusion
- women younger than 18 years women not able or willing to provide written informed consent women with or without infection already receiving antibiotics for other indications women allergic to kefazolin or metronidazole
Key Trial Info
Start Date :
March 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04792710
Start Date
March 8 2021
End Date
June 30 2022
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kalafong Provincial Tertiary Hospital
Pretoria, Gauteng, South Africa